| Rationally designed ACE2-derived peptides inhibit SARS-CoV-2 RC Larue, E Xing, AD Kenney, Y Zhang, JA Tuazon, J Li, JS Yount, PK Li, ... Bioconjugate chemistry 32 (1), 215-223, 2020 | 76 | 2020 |
| Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers J Li, L Zeng, Z Wang, H Chen, S Fang, J Wang, CY Cai, E Xing, X Liao, ... Advanced Materials 34 (1), 2100245, 2022 | 28 | 2022 |
| Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design R Sheng, L Yang, Y Zhang, E Xing, R Shi, X Wen, H Wang, H Sun Bioorganic & Medicinal Chemistry Letters 28 (15), 2599-2604, 2018 | 13 | 2018 |
| BET bromodomain inhibitors: novel design strategies and therapeutic applications KKW To, E Xing, RC Larue, PK Li Molecules 28 (7), 3043, 2023 | 12 | 2023 |
| Size-dependent effect of Cu2O nanocubes in electrochemical and photocatalytic properties Y Tang, Y Xu, C Qi, X Li, E Xing, F Wang, Z Kan, C Wang, J Tang, ... Journal of Nanoscience and Nanotechnology 18 (12), 8282-8288, 2018 | 11 | 2018 |
| Constitutively active androgen receptor in Hepatocellular Carcinoma EJ Montgomery, E Xing, MJ Campbell, PK Li, JS Blachly, A Tsung, ... International journal of molecular sciences 23 (22), 13768, 2022 | 10 | 2022 |
| Mechanistic insights into the allosteric inhibition of androgen receptors by binding function 3 antagonists from an integrated molecular modeling study X Kong, E Xing, T Zhuang, PK Li, X Cheng Journal of Chemical Information and Modeling 61 (7), 3477-3494, 2021 | 6 | 2021 |
| Development of murine leukemia virus integrase-derived peptides that bind Brd4 extra-terminal domain as candidates for suppression of acute myeloid leukemia E Xing, N Surendranathan, X Kong, N Cyberski, JD Garcia, X Cheng, ... ACS Pharmacology & Translational Science 4 (5), 1628-1638, 2021 | 5 | 2021 |
| Computational modeling studies reveal the origin of the binding preference of 3‐(3, 4‐di hydroisoquinolin‐2 (1H)‐ylsulfonyl) benzoic acids for AKR1C3 over its isoforms X Kong, E Xing, S Wu, T Zhuang, PK Li, C Li, X Cheng Protein Science 31 (12), e4499, 2022 | 2 | 2022 |
| SAT021 Development Of Niclosamide Analogs For Treatment Of Androgen Receptor Positive Hepatocellular Carcinoma E Jordan Montgomery, E Xing, A Dauki, H Radomska, S Kiyota Kulp, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 1759, 2023 | | 2023 |
| Design, synthesis, and screening of niclosamide analogs as androgen receptor degraders for hepatocellular carcinoma J Cheng, E Xing, S Mohammed, E Montgomery, L Granchie, C Coss, ... Cancer Research 83 (7_Supplement), 3106-3106, 2023 | | 2023 |
| Design, synthesis and study of small molecules with both AR degradation and AKR1C3 inhibitory activities E Xing, X Kong, W Lou, R Shi, X Cheng, AC Gao, PK Li Cancer Research 80 (16_Supplement), 5681-5681, 2020 | | 2020 |
